ReviewBiophysical reviews2025
QSAR and machine learning methods for prediction of albumin-ligand binding.
Review in Biophysical reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serum albumin is the most abundant protein found in human and mammalian blood plasma. It plays a crucial role in the transport and delivery of various molecules, including drugs. The affinity of small molecule drugs to albumin affects their ADME properties and overall efficacy. Hence, predictive models for albumin-ligand binding constants are of interest for computer-aided drug design. Due to the vast number of potential binding modes to albumin, the application of structure-based approaches relying on calculations of the binding free energy is challenging, while ligand-based QSAR and machine learning approaches can be trained to achieve rather good performance even for structurally diverse molecule sets. We consider the existing albumin affinity datasets and the numerous models designed to predict the affinity, which are based on various machine learning techniques and use different types of molecular descriptors. The transferability of the models to plasma protein binding values is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.